Articles related to BIOMARKERS

“Disruption to the glymphatic system is likely to impair our ability to clear the brain of the amyloid and tau that causes Alzheimer’s disease.” — Hui Hong, University of Cambridge

“The results demonstrate robust effect sizes and good classification accuracy, which are needed for this assay to be adopted and widely used in the early detection and monitoring of AD.”

“Real-world driving behavior appears to be a promising digital biomarker for detecting early cognitive impairment. These subtle, progressive changes in mobility and driving patterns may help clinicians identify emerging cognitive impairment earlier, guide decisions around driving safety, and support timely interventions to preserve independence and mobility in aging adults.” – Neurologist Mill Etienne, MD

Current smoking was the most important predictor for a detrimental effect of aspirin on cancer incidence, whereas CHIP was the most important predictor for a beneficial effect of aspirin, followed by age and a family history of cancer.

These results suggest that PARP inhibition represents a potential treatment strategy in HRR-deficient advanced biliary tract cancer, including the potential platform to investigate novel combination treatment strategies as well as consideration for a more selective biomarker selection.

“The brain is the most powerful sexual organ a person possesses. For there to be injury to the brain as a result of play is a concern. This does not mean that the behavior or frequency of behavior is of concern, but it does call into question the technique that is being used, the consent, and prior negotiations of this type of sexual play.”